Cargando…
Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey
BACKGROUND: Major depressive disorder (MDD) is a recurrent psychiatric condition that presents challenges in responding to treatment and achieving long-term remission. To improve outcomes, a shared decision-making treatment approach with patient and healthcare practitioner (HCP) engagement is vital....
Autores principales: | Raveendran, Subhara, Singh, Deepshikha, Burke, Mary C., McAuliffe-Fogarty, Alicia H., Parikh, Sagar V., McIntyre, Roger S., Roy, Anit, Martin, Michael, Chrones, Lambros, Opler, Mark G. A., Blair, Chris, McCue, Maggie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294329/ https://www.ncbi.nlm.nih.gov/pubmed/37365543 http://dx.doi.org/10.1186/s12888-023-04922-6 |
Ejemplares similares
-
5.13 The Experience of Children and Adolescents With ADHD and Their Caregivers During the COVID-19 Pandemic: The UNCOVER Study
por: Thorley, Eileen Mack, et al.
Publicado: (2021) -
Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
por: McCue, Maggie, et al.
Publicado: (2021) -
Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
por: McCue, Maggie, et al.
Publicado: (2022) -
Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
por: McCue, Maggie, et al.
Publicado: (2022) -
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
por: McIntyre, Roger S
Publicado: (2017)